Literature DB >> 11870430

Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients.

A Coulon1, F Lafitte, K Hoang-Xuan, N Martin-Duverneuil, K Mokhtari, J Blustajn, J Chiras.   

Abstract

Because of the increasing incidence of primary central nervous system lymphoma (PCNSL), it is essential to recognize this disease in order to start appropriate treatment. We present the characteristic CT and MRI features of this tumour. The findings of 32 CT and 31 MR of 37 immunocompetent patients with biopsy-proved PCNSL are reviewed. The main features are presented and analysed, and are discussed in comparison with proven literature data. Primary central nervous system lymphoma presents as supratentorial solitary lesions in approximately 80% of the patients and multiple lesions in 20%. In contrast to classical data, the lesions are located in deep structures only in one-third of the cases, and involve posterior fossa in 10% of cases. Most of the lesions are hyperdense or isodense (92%) on CT, hypointense or isointense on T1-weighted images, and only about 40% are hyperintense on T2-weighted images. Nearly all the lesions enhance, except after corticosteroid administration. They produce mild oedema and mass effect. Meningeal or ventricular enhancement are rare but suggestive. Calcification, haemorrhage or necrosis are scarce. Although PCNSL in immunocompetent patients have a variable CT and MR appearance, the imaging data often suggest the diagnosis.

Entities:  

Mesh:

Year:  2001        PMID: 11870430     DOI: 10.1007/s003300101037

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  43 in total

1.  Multiple calcified primary central nervous system lymphoma with immunodeficiency in a child.

Authors:  Jing-Qi Zhu; Nan-Xin Hao; Wei-Qun Bao; Xiang-Ru Wu
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Unusual radiological presentation of PCNSL.

Authors:  Deepak Agrawal; A K Mahapatra
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

3.  Role of rCBV values derived from dynamic susceptibility contrast-enhanced magnetic resonance imaging in differentiating CNS lymphoma from high grade glioma: a meta-analysis.

Authors:  Ruofei Liang; Mao Li; Xiang Wang; Jiewen Luo; Yuan Yang; Qing Mao; Yanhui Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 4.  Primary central nervous system lymphoma: essential points in diagnosis and management.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

5.  Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.

Authors:  Christian Grommes; James L Rubenstein; Lisa M DeAngelis; Andres J M Ferreri; Tracy T Batchelor
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

6.  Primary Central Nervous System Lymphoma.

Authors:  Denise M. Damek
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

Review 7.  Updates on Primary Central Nervous System Lymphoma.

Authors:  Lauren R Schaff; Christian Grommes
Journal:  Curr Oncol Rep       Date:  2018-02-28       Impact factor: 5.075

8.  Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers.

Authors:  Alan J Wright; Greg A Fellows; John R Griffiths; M Wilson; B Anthony Bell; Franklyn A Howe
Journal:  Mol Cancer       Date:  2010-03-23       Impact factor: 27.401

9.  A case of intraventricular primary central nervous system lymphoma.

Authors:  Kimberly Funaro; Katie C Bailey; Sadie Aguila; Steven J Agosti; Christopher Vaillancourt
Journal:  J Radiol Case Rep       Date:  2014-03-01

Review 10.  A systematic approach to the diagnosis of suspected central nervous system lymphoma.

Authors:  Brian J Scott; Vanja C Douglas; Tarik Tihan; James L Rubenstein; S Andrew Josephson
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.